| abstract |
The invention relates to the field of psychopharmacology. Morenparticularly, the invention relates to the treatment of DSM-III disorders, such asnimpaired interpersonal and behavioral disorders, including sexual disorders suchnas M.E.D. and HS.D.D. The invention provides new therapeutic compositionsnand methods for treating DSM-III disorders, including M.E.D. and H.S.D.D. Thencompositions and methods according to the invention provide improvednawareness and alertness to environment, improved adaptation to environmentnand ability to sustain attention, and increased interest in environment andncapacity for arousal, without increased aggressiveness. |